Walaa R Mahmoud

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Breast Cancer Cells

Molecular Docking

Tyrosine Kinase

Top Venues

Drug development research

Archiv der Pharmazie

This page only lists publications with an associated author ORCID identifier.

Publications

Dana M Odeh, Heba Abdelrasheed Allam, Fady Baselious, Walaa R Mahmoud, Mohanad M Odeh, Hany S Ibrahim, Hatem A Abdel-Aziz, Eman R Mohammed
Design, synthesis, and biological evaluation of dinaciclib and CAN508 hybrids as CDK inhibitors. Drug development research 85 (3) (2024)
Dana M Odeh, Heba Abdelrasheed Allam, Fady Baselious, Walaa R Mahmoud, Mohanad M Odeh, Hany S Ibrahim, Hatem A Abdel-Aziz, Eman R Mohammed
Design, synthesis, and biological evaluation of dinaciclib and CAN508 hybrids as CDK inhibitors. Drug development research 85 (3) (2024)
Nada A A M Aziz, Riham F George, Khaled El-Adl, Walaa R Mahmoud
Design, synthesis, in silico docking, ADMET and anticancer evaluations of thiazolidine-2,4-diones bearing heterocyclic rings as dual VEGFR-2/EGFR T790M tyrosine kinase inhibitors. RSC advances 12 (20) (2022)
Nada A A M Aziz, Riham F George, Khaled El-Adl, Walaa R Mahmoud
Exploration of thiazolidine-2,4-diones as tyrosine kinase inhibitors: Design, synthesis, ADMET, docking, and antiproliferative evaluations. Archiv der Pharmazie (2022)